Aptar Pharma in exclusive partnership with Stallergenes Greer to develop new medical device

USA – Aptar Pharma, a global leader in drug delivery systems, services, and active material science solutions, has formed an exclusive partnership with Stallergenes Greer, a global healthcare company specializing in allergen immunotherapy (AIT), to create the first-of-its-kind connected drug delivery device. The partnership will also see to the development of companion mobile app for patients undergoing Stallergenes Greer’s AIT treatments with sublingual solutions. Non-compliance with an AIT schedule and premature discontinuation of treatment continue to be issues in AIT management. This innovative, user-friendly connected device will help to improve…

Read More

U.S. International Development Finance Corporation and Medical Credit Fund partner to improve maternal healthcare in Sub-Saharan Africa

AFRICA – The United States International Development Finance Corporation (DFC) and Medical Credit Fund, a non-profit organization founded as part of PharmAccess Group, has announced a new collaboration aimed at reducing maternal mortality in Sub-Saharan Africa. This collaboration will result in the design and implementation of a technical assistance facility for health providers in the region that will serve low-income mothers and their families. The effort will be aided by the MOMs (Maternal Outcomes Matter) Initiative, a program launched in June 2019 by DFC, MSD for Mothers, Credit Suisse, and…

Read More

Merck’s phase 3 trials of fixed dose HIV-1 therapy achieve primary endpoint

USA – Merck has announced a positive top-line results from two pivotal Phase 3 trials of the investigational, once-daily oral fixed dose combination pill of doravirine/islatravir (DOR/ISL) in adults with HIV-1 infection who are virologically suppressed on different antiretroviral therapy regimens. The drugmaker has announced that the trials met their safety and efficacy endpoints at 48 weeks in adults with HIV-1 infection who are currently receiving antiretroviral therapy. According to the company, the endpoint is defined as a percentage of participants with HIV-1 RNA levels greater than 50 copies per…

Read More

Genentech’s new continuous release eye treatment gains FDA approval

USA – The FDA has approved ranibizumab 100 mg/mL injection for wet age-related macular degeneration in patients who have previously responded to at least two anti-VEGF injections, according to Genentech. The new therapy (Susvimo), formerly known as the Port Delivery System (PDS) with ranibizumab, is designed for intravitreal use via ocular implant for the treatment of people with wet, or neovascular, Age-Related Macular Degeneration (AMD). This is the only FDA-approved wet AMD therapy that allows for as few as two treatments per year. The availability of Susvimo will decrease the…

Read More

Click Therapeutic secures US$52 million in Series B funding to expand prescription portfolio

USA – Click Therapeutic, a prescription digital therapeutic company, has bagged US$52 million Series B funding round led by Health Catalyst Capital, Revelation Partners, Sanofi, K2 HealthVentures, Hima Ventures, and RidgetopHealth. Other participants included Health Catalyst Capital, Revelation Partners, Sanofi, K2 HealthVentures, Hima Ventures, and RidgetopHealth. This announcement comes more than a year after the company signed a US$500 million-plus deal with pharmaceutical company Boehringer Ingelheim to jointly commercialize a digital treatment for schizophrenia patients. Click’s pipeline of innovative digital therapeutics covers a wide range of therapeutic areas, including psychiatry…

Read More

Sanofi scores sixth win for its versatile monoclonal antibody drug

FRANCE – Regeneron Pharmaceuticals and French major, Sanofi, have announced positive pivotal Phase 3 results from a trial evaluating Dupixent (dupilumab) in adults with uncontrolled prurigo nodularis, a chronic type 2 inflammatory skin disease characterized by severe itching and skin lesions. The trial of the blockbuster met its primary and all key secondary endpoints, demonstrating that Dupixent significantly reduced itch and skin lesions in this investigational setting when compared to placebo. Uncontrolled prurigo nodularis has the highest impact on quality of life of any inflammatory skin disease with intense, chronic…

Read More

Medtronic appoints new Chief Medical Officer for GIT business

IRELAND – Medtronic plc, a global leader in healthcare technology, has hired Dr. Austin L. Chiang, as Chief Medical Officer (CMO) of the Gastrointestinal (GI) business at Medtronic. Chiang is an assistant professor of medicine at Sidney Kimmel Medical College and director of the Endoscopic Bariatric Program at Thomas Jefferson University Hospital, both in Philadelphia. He has a master’s degree in public health from the Harvard T.H. Chan School of Public Health. Dr. Chiang, a nationally recognized gastroenterologist and advanced endoscopist, is passionate about providing accurate medical information to patients…

Read More

FDA gives positive nod for Moderna, J&J COVID vaccine boosters

USA – A month after approving a third dose of Pfizer/BioNTech’s vaccines, the FDA has approved booster shots for Moderna and Johnson & Johnson’s COVID-19 vaccines. It has also approved the use of different vaccines as boosters than those used for primary vaccination – the so-called ‘mix and match’ strategy – based on clinical evidence that this can increase antibody titer. The FDA specifically authorized a third Moderna shot six months after their previous shot for seniors and others at high risk of COVID-19 due to health issues, jobs, or…

Read More

Blockchain to unlock healthcare industry’s full capabilities-Deloitte

USA – Blockchain technology has started permeating industries handling voluminous data, where accuracy is paramount and the presence of error can result in severe damages. Blockchain debut was in the banking industry. However, like the banking industry, healthcare industry is another sensitive area where zero error is required. The healthcare sector is currently plagued with inefficiencies, lack of accuracy, and high administrative costs. The blockchain is a decentralized system that records, stores, and maintains transactional or historical records across a peer-to-peer network of personal computers known as nodes. The blockchain…

Read More

First US hospital installs Siemens Healthineers’ new imaging technology

USA – New York-based Long Island Jewish Valley Stream has become the first healthcare institution in the United States to install the LUMINOS Lotus Max, a premium 2-in-1 remote-controlled imaging system from Siemens Healthineers. The new imaging technology delivers enhanced patient care and streamlines the diagnostic imaging process with better outcomes for patients. The LUMINOS Lotus Max is a remote-controlled, two-in-one fluoroscopy and radiography imaging system that allows medical staff to perform two previously separate imaging tests with one machine and quickly switch between them in a truly integrative manner.…

Read More